Regulatory liabilities, deferred income, and other
4,979
4,942
4,986
5,084
Preferred stock (1 par value 30 million shares authorized at june30, 2026 and december31, 2025 35 thousand shares issued at june30, 2026 and december31, 2025)
35
35
35
35
Common stock (1 par value 1,470 million shares authorized at june30, 2026 and december31, 2025 1,262 million shares issued at june30, 2026 and 1,261 million shares issued at december31, 2025)
1,262
1,262
1,261
1,261
Capital in excess of par value
24,783
24,767
24,801
24,656
Retained deficit
-11,834
-12,017
-12,237
-12,354
Accumulated other comprehensive income (loss)
124
125
127
102
Treasury stock, at cost (39 million shares at june30, 2026 and december31, 2025 of common stock)
1,180
1,180
1,180
1,180
Total stockholders equity
13,190
12,992
12,807
12,520
Noncontrolling interests in consolidated subsidiaries
2,178
2,170
2,188
2,340
Total equity
15,368
15,162
14,995
14,860
Total liabilities and equity
60,610
59,569
58,573
55,736
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.